NCT03958071 A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking Status COMPLETED Phase N/A
NCT03955146 Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE3
NCT03949530 A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis Status TERMINATED Phase PHASE1
NCT03944928 ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution Status COMPLETED Phase N/A
NCT03928847 Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis. Status COMPLETED Phase EARLY_PHASE1
NCT03901196 Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy) Status COMPLETED Phase N/A
NCT03898284 Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT03890250 Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase NA
NCT03865927 GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT03836417 Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study Status COMPLETED Phase N/A
NCT03830125 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03761082 Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy Status COMPLETED Phase N/A
NCT03744598 Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis Status TERMINATED Phase N/A
NCT03733444 A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care Status TERMINATED Phase PHASE3
NCT03727802 Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1